series-c-plus
Stage
2018
Founded
2
Investors
About
Singleron Biotechnologies develops and commercializes single-cell multi-omics products for research and clinical settings, offering instruments, reagents, and software for high-throughput single-cell analysis used in hospitals, research institutes, and pharmaceutical companies.
Explore Singleron Biotechnologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.